For immediate release:
January 22, 2009
PFIZER STATEMENT ON THE PROPOSED PHYSICIAN SUNSHINE ACT
NEW YORK, NY, January 22 -- Pfizer Inc today issued the following
statement on the proposed Physician Sunshine Act:
Pfizer supports efforts by Senators Kohl and Grassley to provide
greater clarity and understanding of the paid collaborations
between healthcare professionals and the pharmaceutical industry.
Pfizer believes these essential collaborations lead to valuable
scientific innovations and improved patient care.
We agree with the senators that sharing this information publicly
in a simple and uniform manner is the best way to provide a
complete picture that will further greater understanding of these
Pfizer is committed to increasing transparency and disclosure of
activities that relate to the public interest:
• In 2002, Pfizer began to register its clinical trials on
the public database www.clinicaltrials.gov. To date, the
company has registered more than 1,000 trials, including
non-interventional studies with prospective data
• Also in 2002, Pfizer began publicly reporting U.S.
• In 2004, Pfizer began publicly posting the results of its
clinical trials at www.clinicalstudyresults.org. Summary
results of more than 800 studies are posted to this Web
site. In addition, the company posts study results on
www.clinicaltrials.gov in accordance with applicable
• In December 2006, the company launched a regularly updated
public Web site, describing all compounds in its drug
development pipeline and detailing their progress.
• In April 2007, Pfizer began posting on www.pfizer.com its
FDA post-marketing commitments relating to the safe and
effective use of Pfizer medicines.
• In June 2007, Pfizer announced its intention to disclose
its grants and charitable contri